文献速递糖尿病肥胖与代谢综合征

系统综述:饮食干预对2型糖尿病成人肠道菌群的有效性评估

Systematic review assessing the effectiveness of dietary intervention on gut microbiota in adults with type 2 diabetes.
PubMed 文献 · Diabetologia · 2018-05-12

本系统综述纳入8项研究,评估饮食和运动干预对2型糖尿病成人肠道菌群及血糖控制的影响。未发现运动干预相关研究;饮食干预与肠道菌群组成和多样性改变相关,HbA1c有统计学显著改善(SMD -2.31 mmol/mol,95%CI -2.76至-1.85,I²=0%,p<0.01),但空腹血糖、空腹胰岛素和HOMA-IR无显著变化。作者认为饮食干预可调节肠道菌群并改善血糖控制,但需进一步开展高质量干预研究。

要点

  • 饮食干预可改变2型糖尿病成人肠道菌群组成和多样性。
  • 饮食干预使HbA1c显著改善(SMD -2.31 mmol/mol,95%CI -2.76至-1.85,I²=0%,p<0.01)。
  • 空腹血糖、空腹胰岛素和HOMA-IR无显著变化。

核心结论

  • 饮食干预可调节2型糖尿病成人肠道菌群并改善血糖控制,但纳入研究结果令人鼓舞的同时,本综述强调需进一步开展设计良好的干预研究以指导靶向肠道菌群的饮食干预的临床使用。

研究设计与样本

  • 系统综述,系统检索报告饮食和/或体力活动/运动干预对确诊2型糖尿病成人肠道菌群和血糖控制影响的研究,共纳入8项符合纳入标准的研究。
  • 采用数据提取表捕获研究特征、方法学质量和干预相关细节,在数据充足时进行Meta分析,其他结果以叙述性方式报告。

主要发现

  • 未发现报告体力活动/运动对肠道菌群和血糖控制影响的研究;报告饮食干预的研究显示饮食干预与肠道菌群组成和多样性改变相关。
  • 与对照组相比,饮食干预使HbA1c有统计学显著改善(SMD -2.31 mmol/mol,95%CI -2.76至-1.85;0.21%,95%CI -0.26至-0.16;I²=0%,p<0.01)。
  • 与对照组相比,饮食干预对空腹血糖(SMD -0.25 mmol/l,95%CI -0.85至0.35,I²=87%,p>0.05)、空腹胰岛素(SMD -1.82 pmol/l,95%CI -7.23至3.60,I²=54%,p>0.05)和HOMA-IR(SMD -0.15,95%CI -0.63至0.32,I²=69%,p>0.05)无显著变化。
  • 与对照组相比,饮食干预对双歧杆菌属(SMD 1.29%,95%CI -4.45至7.03,I²=33%,p>0.05)、罗斯氏菌属(SMD -0.85%,95%CI -2.91至1.21,I²=79%,p>0.05)和乳杆菌属(SMD 0.04%,95%CI -0.01至0.09,I²=0%,p>0.05)相对丰度无显著变化。
  • 肠道菌群在其他方面有显著变化,包括门、科、属和种等分类水平的变化、厚壁菌门与拟杆菌门比值以及多样性矩阵(α和β)的变化;饮食干预对炎症、短链脂肪酸或人体测量学指标影响极小或无影响。

关键数值与推荐

  • Meta分析中,与对照组相比,饮食干预使HbA1c的SMD为-2.31 mmol/mol(95%CI -2.76至-1.85;0.21%,95%CI -0.26至-0.16),I²=0%,p<0.01。
  • 与对照组相比,饮食干预对空腹血糖的SMD为-0.25 mmol/l(95%CI -0.85至0.35),I²=87%,p>0.05。
  • 与对照组相比,饮食干预对空腹胰岛素的SMD为-1.82 pmol/l(95%CI -7.23至3.60),I²=54%,p>0.05。
  • 与对照组相比,饮食干预对HOMA-IR的SMD为-0.15(95%CI -0.63至0.32),I²=69%,p>0.05。
  • 与对照组相比,饮食干预对双歧杆菌属、罗斯氏菌属和乳杆菌属相对丰度的SMD分别为1.29%(95%CI -4.45至7.03,I²=33%,p>0.05)、-0.85%(95%CI -2.91至1.21,I²=79%,p>0.05)和0.04%(95%CI -0.01至0.09,I²=0%,p>0.05)。

临床怎么用

  • 原文未据此给出推荐。
  • 作者认为,尽管纳入研究结果令人鼓舞,本综述强调需进一步开展设计良好的干预研究以指导靶向肠道菌群的饮食干预的临床使用。

局限性

  • 本综述强调需进一步开展设计良好的干预研究以指导靶向肠道菌群的饮食干预的临床使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Despite improved understanding of the pathophysiology of type 2 diabetes mellitus, explanations for individual variability in disease progression and response to treatment are incomplete. The gut microbiota has been linked to the pathophysiology of type 2 diabetes mellitus and may account for this variability. We conducted a systematic review to assess the effectiveness of dietary and physical activity/exercise interventions in modulating the gut microbiota and improving glucose control in adults with type 2 diabetes mellitus. METHODS: A systematic search was conducted to identify studies reporting on the effect of dietary and physical activity/exercise interventions on the gut microbiota and glucose control in individuals with a confirmed diagnosis of type 2 diabetes mellitus. Study characteristics, methodological quality and details relating to interventions were captured using a data-extraction form. Meta-analyses were conducted where sufficient data were available, and other results were reported narratively. RESULTS: Eight studies met the eligibility criteria of the systematic review. No studies were found that reported on the effects of physical activity/exercise on the gut microbiota and glucose control. However, studies reporting on dietary interventions showed that such interventions were associated with modifications to the composition and diversity of the gut microbiota. There was a statistically significant improvement in HbA1c (standardised mean difference [SMD] -2.31 mmol/mol [95% CI -2.76, -1.85] [0.21%; 95% CI -0.26, -0.16]; I2 = 0%, p < 0.01), but not in fasting blood glucose (SMD -0.25 mmol/l [95% CI -0.85, 0.35], I2 = 87%, p > 0.05), fasting insulin (SMD -1.82 pmol/l [95% CI -7.23, 3.60], I2 = 54%, p > 0.05) or HOMA-IR (SMD -0.15 [95% CI -0.63, 0.32], I2 = 69%, p > 0.05) when comparing dietary interventions with comparator groups. There were no significant changes in the relative abundance of bacteria in the genera Bifidobacterium (SMD 1.29% [95% CI -4.45, 7.03], I2 = 33%, p > 0.05), Roseburia (SMD -0.85% [95% CI -2.91, 1.21], I2 = 79%, p > 0.05) or Lactobacillus (SMD 0.04% [95% CI -0.01, 0.09], I2 = 0%, p > 0.05) when comparing dietary interventions with comparator groups. There were, however, other significant changes in the gut microbiota, including changes at various taxonomic levels, including phylum, family, genus and species, Firmicutes:Bacteroidetes ratios and changes in diversity matrices (α and β). Dietary intervention had minimal or no effect on inflammation, short-chain fatty acids or anthropometrics. CONCLUSIONS/INTERPRETATION: Dietary intervention was found to modulate the gut microbiota and improve glucose control in individuals with type 2 diabetes. Although the results of the included studies are encouraging, this review highlights the need for further well-conducted interventional studies to inform the clinical use of dietary interventions targeting the gut microbiota.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Houghton D, Hardy T, Stewart C, et al. Systematic review assessing the effectiveness of dietary intervention on gut microbiota in adults with type 2 diabetes. Diabetologia. 2018. PMID: 29754286. doi:10.1007/s00125-018-4632-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。